Nuveen LLC Buys Shares of 34,831 Nature's Sunshine Products, Inc. $NATR

Key Points

• Nuveen LLC invested approximately $437,000 in Nature's Sunshine Products, acquiring 34,831 shares during the first quarter, increasing its ownership to 0.19% of the company.
• Nature's Sunshine Products recently reported an earnings per share (EPS) of $0.35, outperforming analyst expectations of $0.16, with revenue totaling $114.75 million.
• In a positive development, Canaccord Genuity Group raised its price target for the company's stock from $21.00 to $22.00, maintaining a "buy" rating.

Nuveen LLC bought a new stake in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 34,831 shares of the company's stock, valued at approximately $437,000. Nuveen LLC owned about 0.19% of Nature's Sunshine Products as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Wells Fargo & Company MN lifted its stake in Nature's Sunshine Products by 28.8% during the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock valued at $106,000 after buying an additional 1,611 shares in the last quarter. Barclays PLC lifted its position in shares of Nature's Sunshine Products by 5.9% in the 4th quarter. Barclays PLC now owns 37,693 shares of the company's stock valued at $552,000 after acquiring an additional 2,091 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Nature's Sunshine Products by 3.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 856,701 shares of the company's stock worth $12,560,000 after purchasing an additional 30,464 shares during the period. Northern Trust Corp boosted its stake in Nature's Sunshine Products by 2.7% in the 4th quarter. Northern Trust Corp now owns 119,005 shares of the company's stock worth $1,745,000 after purchasing an additional 3,174 shares during the period. Finally, Ameriprise Financial Inc. grew its position in Nature's Sunshine Products by 16.8% during the 4th quarter. Ameriprise Financial Inc. now owns 51,182 shares of the company's stock worth $750,000 after purchasing an additional 7,348 shares in the last quarter. Hedge funds and other institutional investors own 79.40% of the company's stock.

Wall Street Analysts Forecast Growth

NATR has been the subject of several research reports. DA Davidson restated a "buy" rating and set a $19.00 price target on shares of Nature's Sunshine Products in a report on Tuesday, June 3rd. Canaccord Genuity Group increased their target price on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $19.67.

Insider Activity

In related news, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the firm's stock in a transaction on Friday, June 27th. The shares were sold at an average price of $11.46, for a total value of $32,713,796.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Jonathan David Lanoy sold 5,000 shares of the business's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $16.51, for a total transaction of $82,550.00. Following the transaction, the chief accounting officer directly owned 50,051 shares of the company's stock, valued at approximately $826,342.01. This represents a 9.08% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,879,275 shares of company stock worth $33,123,599. 4.70% of the stock is owned by company insiders.

Nature's Sunshine Products Stock Up 0.3%

Shares of NASDAQ:NATR traded up $0.05 on Wednesday, reaching $17.15. The company had a trading volume of 72,838 shares, compared to its average volume of 104,133. The stock has a market capitalization of $302.53 million, a P/E ratio of 23.18 and a beta of 1.11. The stock has a 50-day moving average price of $15.92 and a 200 day moving average price of $14.35. Nature's Sunshine Products, Inc. has a twelve month low of $11.01 and a twelve month high of $18.06.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.35 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.19. Nature's Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%.The business had revenue of $114.75 million for the quarter, compared to analyst estimates of $113.10 million. Nature's Sunshine Products has set its FY 2025 guidance at EPS.

About Nature's Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.